千維健膠囊食品
千維健膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
règlement (UE) 2022/63. Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, retrieved 23 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| CAYENNE FRUIT | CAYENNE FRUIT | Not identified |
| DESICCATED LIVER POWDER | DESICCATED LIVER POWDER | Not identified |
| SOYBEAN EXTRACT | SOYBEAN EXTRACT | Not identified |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE | Vitamine E |
| PHYLLANTHUS URINARIA L. EXTRACT | PHYLLANTHUS URINARIA L. EXTRACT | Not identified |
| ARTICHOKE POWDER | ARTICHOKE POWDER | Not identified |
| ROYAL JELLY | ROYAL JELLY | Gelée royale |
| BEE POLLEN | BEE POLLEN | Not identified |
| SAFFLOWER SEED OIL | SAFFLOWER SEED OIL | Not identified |
| WHEAT GERM OIL | WHEAT GERM OIL | Huile de germes de blé |
| RIBOFLAVIN | RIBOFLAVIN | Vitamine B2 (riboflavine) |
| PYRIDOXINE HYDROCHLORIDE | PYRIDOXINE HYDROCHLORIDE | Vitamine B6 |
| CYANOCOBALAMIN | CYANOCOBALAMIN | Vitamine B12 |
| GELATIN | GELATIN | Not identified |
| WATER | WATER | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| BEESWAX | BEESWAX | Not identified |
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | Not identified |
| SUNSET YELLOW FCF | SUNSET YELLOW FCF | Not identified |
| ALLURA RED AC | ALLURA RED AC | Not identified |
| BRILLIANT BLUE FCF | BRILLIANT BLUE FCF | Not identified |
| SORBIC ACID | SORBIC ACID | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- 1139038075
- Chinese name
- 千維健膠囊食品
- English name
- COMBETASI SOFTGEL CAPSULES
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 雄美有限公司
- Registration date
- 2024-06-18
- Published validity end
- 2029-06-18
Original register data
View published fields and their variants
- Product name
- 千維健膠囊食品
- Active ingredients
- CAYENNE FRUIT;;DESICCATED LIVER POWDER;;SOYBEAN EXTRACT;;DL-ALPHA TOCOPHERYL ACETATE;;PHYLLANTHUS URINARIA L. EXTRACT;;ARTICHOKE POWDER;;ROYAL JELLY;;BEE POLLEN;;SAFFLOWER SEED OIL;;WHEAT GERM OIL;;RIBOFLAVIN;;PYRIDOXINE HYDROCHLORIDE;;CYANOCOBALAMIN;;GELATIN;;WATER;;GLYCEROL;;BEESWAX;;TITANIUM DIOXIDE;;SUNSET YELLOW FCF;;ALLURA RED AC;;BRILLIANT BLUE FCF;;SORBIC ACID;;
- Valid until
- 1180618
- Registration number
- 1139038075
- Licence holder
- 雄美有限公司
- Registration date
- 1130618
- Published reference
- DHC0B390380751
- Published English name
- COMBETASI SOFTGEL CAPSULES
Official source
View the official register, number 1139038075
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- ROYAL JELLY
Read the warning, when it applies and the studies cited
ROYAL JELLY
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Contraindications
Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).
Sources cited by Health Canada (8)
- Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
- TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).
Sources cited by Health Canada (6)
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.